AC Immune (ACIU) Change in Accured Expenses (2017 - 2025)

AC Immune (ACIU) has 9 years of Change in Accured Expenses data on file, last reported at -$4.7 million in Q4 2025.

• Quarterly Change in Accured Expenses fell 328.95% year-over-year to -$4.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.7 million (down 407.74% YoY) and the FY2025 annual result came in at -$4.7 million, down 397.12% from the prior year.
• Change in Accured Expenses fell to -$4.7 million in Q4 2025 per ACIU's latest filing, from $645056.5 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.3 million in Q4 2021 and bottomed at -$5.6 million in Q1 2022.
• The 5-year median for Change in Accured Expenses is $399811.7 (2025), against an average of -$55722.4.
• The widest annual swing landed in 2021, when Change in Accured Expenses surged 4222.27%; it then tumbled 3746.87% in 2025.
• Tracing ACIU's Change in Accured Expenses over 5 years: stood at $3.3 million in 2021, then slumped by 83.23% to $561217.5 in 2022, then surged by 148.08% to $1.4 million in 2023, then tumbled by 178.71% to -$1.1 million in 2024, then plunged by 328.95% to -$4.7 million in 2025.
• Per Business Quant, the three latest ACIU Change in Accured Expenses figures stand at -$4.7 million (Q4 2025), $645056.5 (Q3 2025), and $399811.7 (Q2 2025).

Peer Comparison